Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hypoxic-ischemic Encephalopathy
100%
Neonate
53%
Therapeutic Hypothermia
46%
Preterm Infants
37%
Childrens
30%
Neonatal Intensive Care Unit
28%
Gestational Age
25%
Neurodevelopmental Outcome
21%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
21%
Retinopathy of Prematurity
21%
Neurodevelopmental Impairment
19%
Bronchopulmonary Dysplasia
17%
Erythropoietin
15%
Encephalopathy
15%
Odds Ratio
14%
Brain Injury
13%
Length of Stay
13%
Practice Variation
13%
At Discharge
12%
Short-term Outcomes
12%
Brain-derived Neurotrophic Factor
12%
Neonatal Encephalopathy
12%
Asphyxia
11%
Electroencephalography
11%
Children's Hospitals Neonatal Consortium
10%
Social Determinants of Health (SDoH)
9%
Survivors
8%
Congenital Diaphragmatic Hernia
8%
Centre Variation
8%
Neonatal Clinical Trials
8%
2-year Outcome
8%
Posthemorrhagic Hydrocephalus
8%
Lipid Rafts
8%
L1 Cell Adhesion Molecule (L1CAM)
8%
Neonatal Abstinence Syndrome
8%
Anemia of Prematurity
8%
Prematurity
8%
Amyloid Precursor Protein
8%
Necrotizing Enterocolitis
8%
Postnatal Outcome
8%
Antenatal Factors
8%
Age Correlation
8%
Patent Ductus Arteriosus
8%
Confidence Interval
8%
Intraventricular Hemorrhage
8%
Risk Factors
7%
High Dose
7%
Endotracheal Tube
7%
Raft
7%
Seizure
6%
Medicine and Dentistry
Hypoxic-Ischemic Encephalopathy
68%
Neonatal Intensive Care Unit
44%
Neonate
42%
Brain Disease
38%
Induced Hypothermia
37%
Gestational Age
24%
Prematurity
23%
Extracorporeal Membrane Oxygenation
22%
Lung Dysplasia
21%
Retinopathy of Prematurity
18%
Hypoxic Ischemic Encephalopathy
17%
Erythropoietin
16%
Odds Ratio
15%
Magnetic Resonance Imaging
15%
Social Determinants of Health
12%
Asphyxia
12%
Epileptic Seizure
11%
Primary Outcome
11%
Health Care Cost
10%
Logistic Regression Analysis
9%
Clinical Trial
9%
Bayley Scales of Infant Development
9%
Congenital Diaphragm Hernia
8%
Patent Ductus Arteriosus
8%
Necrotizing Enterocolitis
8%
Anemia
8%
Cord Blood
8%
Drug Megadose
8%
Brain Injury
8%
Quality Improvement
7%
Placebo
7%
Neonatal Infant
7%
Scoring System
6%
Diseases
6%
Genetic Screening
5%
Cross Sectional Study
5%
Respiratory Failure
5%
Patient Care
5%
Extubation
5%
Neonatal Extracorporeal Membrane Oxygenation
5%
Retrospective Study
5%
Cerebral Hemorrhage
5%
Newborn Infant
5%